Clinical trial · no report yet · Phase not applicable
STEREO-RE-PRO
Efficacy of Repeat Stereotactic Radiation in Patients With Intraprostatic Tumor Recurrence
- NCT03438552 ↗
- Active, not recruiting
- UNICANCER
- Focused
We haven't built a report for this trial yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Preliminary discovery
Commentary in our index that names this trial so far
Podcasts, YouTube videos and X posts we have indexed. A report screens them, searches for more and cites what clinicians said when it is built, so final coverage is set at build.
| Channel | Found | |
|---|---|---|
| X threads | 3 |
The trial
ClinicalTrials.gov- Official title
- Phase I/II Multi-center Study Evaluating the Efficacy of Repeat Stereotactic Radiation in Patients With Intraprostatic Tumor Recurrence After External Radiation Therapy
- Phase
- Phase not applicable
- Status
- Active, not recruiting
- Conditions
- Local Recurrence of Malignant Tumor of Prostate
- Interventions
- Stereotactic Body Radiotherapy
- Arms
- SBRT at a total dose of 30 Gy · Experimental
- SBRT at a total dose of 25 Gy · Experimental
- SBRT at a total dose of 36 Gy · Experimental
- Enrollment
- 57
- Primary outcomes
- Selection of the recommended dose for salvage-SBRT (either 5 x 6 Gy, 6 x 6 Gy, or 5 x 5 Gy) based on dose-limiting toxicity observed during the 18 weeks following the initiation of salvage-SBRT.
- Estimate the efficacy of the salvage-SBRT in terms of biochemical relapse-free survival rate
- Sponsor
- UNICANCER
- Start
- Oct 18, 2018
- Primary completion
- Oct 15, 2027 (estimated)
- Results posted
- No
- Registry record
- NCT03438552 · updated Dec 20, 2024
Publications
linked from the registry- Pasquier D, Le Deley MC, Tresch E, Cormier L, Duterque M, Nenan S, Lartigau E. GETUG-AFU 31: a phase I/II multicentre study evaluating the safety and efficacy of salvage stereotactic radiation in patients with intraprostatic tumour recurrence after external radiation therapy-study protocol. BMJ Open. 2019 Aug 2;9(8):e026666. doi: 10.1136/bmjopen-2018-026666. PubMed 31377694